Hold Aurobindo Pharma, may test Rs 870: Sandeep Wagle

Sandeep Wagle of powermywealth.com told CNBC-TV18, "I would recommend a hold Aurobindo Pharma with a stoploss of Rs 610. I would talk of the next 12-15 months, I would talk of Rs 850-870 kind of a target and then we will revise it if required."

He further added, "I have much higher targets over a two to three year time horizon, so a hold as of now. I would want to give a disclosure that I personally hold it in my portfolio as well as my family portfolio."